Anbio Biotechnology

Executive Summary

Anbio Biotechnology, founded in 2003 and headquartered in Hamburg, Germany, is a private diagnostics company specializing in laboratory and point-of-care (POCT) diagnostic instruments and assays. The company develops innovative solutions for detecting a wide range of biomarkers across various diseases, aiming to make diagnostics more accessible and affordable. With over two decades of experience, Anbio has established itself as a reliable supplier in the European diagnostics market, focusing on advancing scientific frontiers in biomarker detection. While the company is private and not publicly traded, its steady presence in the industry suggests a solid operational foundation and a niche position in the competitive diagnostics landscape.

Upcoming Catalysts (preview)

• Q3 2026New Product Launch for High-Sensitivity Biomarker Detection65% success
• Q4 2026IVDR Certification for Existing Assay Portfolio70% success
• TBDStrategic Partnership with Major European Distributor50% success